Cargando…
Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial
OBJECTIVE: To determine the longer-term effects of metformin treatment and behavioral weight loss on gut microbiota and short-chain fatty acids (SCFAs). RESEARCH DESIGN AND METHODS: We conducted a 3-parallel-arm, randomized trial. We enrolled overweight/obese adults who had been treated for solid tu...
Autores principales: | Mueller, Noel T., Differding, Moira K., Zhang, Mingyu, Maruthur, Nisa M., Juraschek, Stephen P., Miller, Edgar R., Appel, Lawrence J., Yeh, Hsin-Chieh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323185/ https://www.ncbi.nlm.nih.gov/pubmed/34006565 http://dx.doi.org/10.2337/dc20-2257 |
Ejemplares similares
-
A behavioral weight-loss intervention, but not metformin, decreases a marker of gut barrier permeability: Results from the SPIRIT randomized trial
por: Tilves, Curtis, et al.
Publicado: (2022) -
Dietary intake of adults with and without diabetes: results from NHANES 2013–2016
por: McClure, Scott T, et al.
Publicado: (2020) -
Increases in Circulating and Fecal Butyrate are Associated With Reduced Blood Pressure and Hypertension: Results From the SPIRIT Trial
por: Tilves, Curtis, et al.
Publicado: (2022) -
Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial
por: Juraschek, Stephen P, et al.
Publicado: (2016) -
Effects of a Behavioral Weight Loss Intervention and Metformin Treatment on Serum Urate: Results from a Randomized Clinical Trial
por: Hu, Jiun-Ruey, et al.
Publicado: (2021)